Inflammation Targeting and Responsive Multifunctional Drug‐Delivery Nanoplatforms for Combined Therapy of Rheumatoid Arthritis
Small · 2025
DOI: 10.1002/smll.202500113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Hongyang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Institute of Functional Nano and Soft Materials (FUNSOM) and Collaborative In…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Inflammation, Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Science and Technology Development Fund, Macau SAR.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent inflammation, joint swelling, pain, and progressive joint destruction. Methotrexate (MTX) is the standard first‐line treatment for RA, but its clinical application is hindered by poor water solubility and non‐specific delivery. In this work, a multifunctional drug‐delivery nanoplatform that targets both macrophages and tumor necrosis factor α (TNFα) is developed to enhance the therapeutic efficacy of MTX in RA. The nanoplatform consists of folic acid (FA, for macrophage targeting) and a TNFα‐specific Aptamer (TNFα‐Apt), facilitating a dual‐targeting strategy that significantly improves the accumulation of MTX at the sites of RA lesions (≈3.5‐fold). Moreover, the manganese dioxide (MnO₂) and polydopamine (PDA) coatings on the nanoplatform effectively scavenge reactive oxygen species (ROS), generate oxygen, and promote the polarization of pro‐inflammatory M1 macrophages to the anti‐inflammatory M2 macrophages. This shift in macrophage polarization restores the expression of key inflammatory cytokines, improving the local inflammatory microenvironment. Ultimately, the nanoplatform significantly ameliorates the inflammation and joint damage in a collagen‐induced arthritis (CIA) model, suggesting that this multi‐target combination therapy holds considerable potential for the treatment of RA in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Institute of Functional Nano and Soft Materials (FUNSOM) and Collaborative Innovation Center of Suzhou Nano Science and Technology (NANO-CIC), Sooc…
- Suzhou Key Laboratory of Nanotechnology and Biomedicine, Soochow University, Suzhou, 215123, China.
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore, 637371, Singapore.
- Department of Orthopaedics, Second Affiliated Hospital of Soochow University, Osteoporosis Research Institute of Soochow University, Suzhou, 215000, China.
- Macao Translational Medicine Center, Macau University of Science and Technology, Taipa, Macau SAR, 999078, China.
- Macao Institute of Materials Science and Engineering, Macau University of Science and Technology, Taipa, Macau SAR, 999078, China.
ORCID-Profile: Binbin Chu, Yao He
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Science and Technology Development Fund, Macau SAR
- Program for Jiangsu Specially Appointed Professors to Prof. Yao He
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- 111 Project
- Collaborative Innovation Center of Suzhou Nano Science and Technology
- National Key Research and Development Program of China
Zitieren
APA
Li, H., Jin, X., Chu, B., Zhang, K., Qin, X., Pan, S., Zhao, Y., Shi, H., Zhang, J., Wang, H., Wen, Z., He, Y., & Sun, X. (2025). Inflammation Targeting and Responsive Multifunctional Drug‐Delivery Nanoplatforms for Combined Therapy of Rheumatoid Arthritis. Small. https://doi.org/10.1002/smll.202500113
Vancouver
Li H, Jin X, Chu B, Zhang K, Qin X, Pan S, et al. Inflammation Targeting and Responsive Multifunctional Drug‐Delivery Nanoplatforms for Combined Therapy of Rheumatoid Arthritis. Small. 2025. doi:10.1002/smll.202500113
BibTeX
@article{Li2025,
author = {Li, Hongyang and Jin, Xiangbowen and Chu, Binbin and Zhang, Kai and Qin, Xuan and Pan, Sheng and Zhao, Yadan and Shi, Haoliang and Zhang, Jiawei and Wang, Houyu and Wen, Zhen and He, Yao and Sun, Xuhui},
title = {Inflammation Targeting and Responsive Multifunctional Drug‐Delivery Nanoplatforms for Combined Therapy of Rheumatoid Arthritis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202500113}
}
EUVIMED